Cancer BiologybioRxiv
Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC
K. Lankes, Z. Hassan, M. J. Doffo…·M. Wirth
The paper identifies bortezomib as a potential therapy for MYC hyperactive pancreatic cancer by showing its sensitivity to proteasome inhibition.